End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 RON | -2.35% | +4.52% | +49.10% |
May. 15 | Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 28 | Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 1,352
Sales per Business
RON in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 366 | 100.0 % | 483 | 100.0 % | +31.80% |
Sales per region
RON in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Romania
100.0
%
| 366 | 100.0 % | 483 | 100.0 % | +31.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ioan Nani
CEO | Chief Executive Officer | 64 | 86-12-31 |
Director of Finance/CFO | 56 | 90-12-31 | |
Cornelia Moraru
CTO | Chief Tech/Sci/R&D Officer | 58 | 03-01-04 |
Investor Relations Contact | - | - | |
Mihaela Murariu
HRO | Human Resources Officer | 46 | 22-09-06 |
Liviu Vatavu
LAW | General Counsel | 51 | 19-01-08 |
Ovidiu Bataga
SAM | Sales & Marketing | 46 | 01-01-31 |
Vasile Chebac
PRN | Corporate Officer/Principal | 69 | 71-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ioan Nani
CEO | Chief Executive Officer | 64 | 86-12-31 |
Mihai Trifu
BRD | Director/Board Member | 41 | 21-08-25 |
Director/Board Member | 48 | 21-08-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 671,338,040 | 117,937,079 ( 17.57 %) | 0 | 17.57 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+49.10% | 304M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- ATB Stock
- Company Antibiotice S.A.